Operating with a Robot
José Oberholzer was one of the first worldwide to perform organ transplants using robotic assistance. He now mentors the next generation of surgeons.
Medicine and Dentistry
Article list Medicine and Dentistry
-
-
AI Meets CRISPR for Precise Gene Editing
The powerful new method opens the door to more accurate modeling of human diseases and lays the groundwork for next-gen gene therapies. -
Swiss Genome of the 1918 Influenza Virus Reconstructed
Researchers discovered that the virus already had key adaptations to the human host at the beginning of the world's deadliest influenza pandemic. -
Biomedicine Inspires at Osaka Expo
Stem cell researcher Melanie Generali shares how UZH scientists brought high-tech medicine to the public at the Expo in Osaka – without resorting to jargon. -
Mapping Disease Across the Globe
Thomas Van Boeckel investigates environmental factors, global patterns of infectious disease and antibiotic resistance in order to better combat these issues. -
“ADHD is complex. There are no black and white answers.”
Molecular neuroscientist Edna Grünblatt uses stem cells from individuals with ADHD to investigate how certain neurons in the brain develop and how medication works. -
Study Traces Transmission Routes in Largest Diphtheria Outbreak in Western Europe in 70 Years
Data from the outbreak indicate transmission routes along established migration pathways into Europe. Although rapid interventions successfully contained the outbreak, these strains continue to cause new infections. -
Intestinal Bacteria Influence Aging of Blood Vessels
Researchers have shown for the first time that intestinal bacteria and their metabolites contribute directly to vascular aging. -
43,000 Data Points against Melanoma
Every tumor is unique. In a new study, scientists from Zurich and Basel used advanced technologies to create individual profiles for precise tumor treatment. -
Poisoned Bodies
Many rare diseases affect the body’s metabolism. The URPP ITINERARE explores these diseases with the aim of developing new therapies. -
Saving Miles
Rocco Bagutti analyzed researchers’ travel behavior for his Master’s thesis. His study has been recognized with a semester award. -
500,000 Francs for Pioneering Research
The Gretener-Thürlemann Prize at the University of Zurich is awarded in its first year to researchers in the field of translational/clinical medicine. -
Digital Assistant for Cancer Treatment
AI has the ability to advance precision cancer treatment by using data to predict the course of the disease with greater accuracy. This saves resources and precious time. -
Retinal Clues to Mental Health
A new study has shown that evidence of genetic susceptibility to schizophrenia can be found in the retina. This finding could help improve the early detection of the disorder. -
New Urine Test for Prostate Cancer Screening
In the future, a simple urine test could detect early-stage prostate cancer. In this interview, the developers tell the story of their invention. -
Towards a Quicker Diagnosis
Medical student Marlene Münger devoted her Master’s thesis to the topic of diagnosing congenital immune deficiencies. She received a semester award for her achievement. -
Decoys Restore Antiviral Immune Defense
Defects in the immune system are caused by antibodies that inhibit important defense proteins. UZH researchers have now generated "decoy molecules" that can intercept these autoantibodies. -
Efficient Development of Drugs with Fewer Mice
With a novel technology, around 25 antibodies can now be tested simultaneously in a single mouse. This should speed up the R&D pipeline for new drugs and hugely reduce the number of animals required. -
Understanding Youth Violence
From family problems to lack of self-control to social disadvantage, the causes of youth violence are complex. We look at the reasons and what really helps people get back on track. -
Promising Active Ingredient for Lupus Therapy
In lupus, the immune system attacks its own structures, causing inflammation and organ damage. A new study shows that natural active ingredient gluconolactone could offer a more targeted therapy.